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Purpose: The purpose of this study was to investigate the importance of initial screening tests for 
depression and anxiety disorders in children with headache. In addition, this study evaluated whether 
the Children’s Depression Inventory (CDI) and Revised Children’s Manifest Anxiety Scale (RCMAS) are 
suitable for screening symptoms of depression and anxiety.
Methods: A retrospective chart review was conducted of 720 children aged 7–17 years who had 
visited a pediatric neurology clinic for headaches and were referred to a pediatric psychiatric clinic 
for psychiatric symptoms from January 2010 to December 2011. All patients completed the CDI 
and RCMAS. Among them, charts of patients with clinically significant total scores (cutoff>15) for 
psychiatric symptoms, as defined by the CDI and RCMAS scoring scales, were reviewed.
Results: Nineteen patients had headaches and clinically significant total scores for psychiatric 
symptoms. The mean age at headache diagnosis was 11.7 years, and 57% were male. Mean duration 
of headache was 11.5 months. Two point eight percent of the patients were diagnosed with psychiatric 
disorders including major depression (1.7%), generalized anxiety disorder (1.1%), and bipolar disorder 
(0.1%). Four patients (0.6%) were diagnosed with attention deficit/hyperactivity disorder (ADHD). 
Total mean CDI and RCMAS scores of patients referred to the psychiatric clinic were 18.8 and 22.2, 
respectively. There was no correlation between CDI or RCMAS total scores and headache frequency, 
duration, or severity.
Conclusion: We recommend that all patients with headache should be screened for depression and 
anxiety by CDI and RCMAS scores. 
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Introduction 
Headache is common among children and adolescents. Epidemiological studies 
suggest that 10%–30% of children and adolescents reported weekly or daily headaches 
and 9%–33% of patients suffer from a primary headache at least monthly1-3). Psychiatric 
comorbidity, especially depression and anxiety, has been well documented in patients 
with primary headaches. In addition, headache in childhood and adolescence is associated 
with behavioral and emotional disorders. Psychiatric problems in headache patients are 
associated with decreased quality of life, poorer prognosis, chronification of disease, and 
poorer response to treatment4). The early identification of psychiatric problems in patients 
with headache is crucial also for headache treatment and prognosis. These prevalence 
and impact, several recent studies suggest that patients with headaches in primary care 
should receive at least brief screenings for psychiatric disorders4,5). However, in children, the 
research on the relationship between headache and psychiatric disorders has received less 
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attention.
In our clinical experience, headache patients with psychiatric 
symptoms had improvement in headache with psychiatric 
medication and psychotherapy for psychiatric symptoms. The aim 
of this study was to investigate the importance of initial screening 
for psychiatric symptoms, especially depression and anxiety, in 
children with headache.
Materials and methods
1. Subjects and procedures
This study is a retrospective chart review of children, who 
were seen in a pediatric neurology clinic for headaches and 
were referred to pediatric psychology clinic for presumed psy-
chiatric disorders from January 2010 to December 2011. A total 
of 720 patients were sent for headaches diagnoses in a pediatric 
neurology clinic and 20 of these patients were referred for 
assessment of psychiatric disorders. This study reviewed the 
charts of all patients after informed written consent was obtained 
from each patient’s parents.
All patients completed a structured headache questionnaire, 
which included questions about demographic characteristics and 
clinical features, and Children’s Depression Inventory (CDI) and 
Revised Manifest Anxiety Scale for Children (RCMAS) at their 
initial visit to the neurology clinic. Demographic characteristics 
included age, sex and clinical data about the headache such as 
first onset age, duration, frequency, nature, locus, presymptoms, 
headache intensity, associated symptoms, family history of 
headaches, family history of psychiatric disorders, and medication 
history including headache or psychiatric medication in the past. 
A thorough headache history and neurologic examination were 
also performed by a neurologist.
2. Measures
Headache frequency was the average monthly headache fre-
quency during the last three months. Headache intensity was 
assessed on an 11-point pain scale (0–10) with 0 indicating ‘no 
headache pain’ and 10 indicating ‘most severe pain possible’. 1–3 
was defined as ‘mild’; 4–6 as ‘moderate’; and 7–10 as ‘severe’. 
Headache type was classified using the International Classification 
of Headache Disorders, 2nd edition diagnostic criteria. 
Symptoms of depression were measured using the CDI. This 
is a well-established self-rating screening tool (reliability, 0.87) 
with 27 statements on rated on a 3-point (0–2) scale. For each 
statement, the child is asked to select the response that best 
describes his or her feelings in the preceding two weeks. There is 
a total CDI score, and 5 subscales: negative mood, interpersonal 
problem, ineffectiveness, anhedonia, and negative self-esteem. 
CDI has been validated in children aged 7–17 years and is one 
of the most commonly used screening methods for childhood 
depression. 
Symptoms of anxiety were measured using the RCMAS. It 
is a self-reported screening tool (reliability, 0.94) to measure 
anxiety in children aged 6–19 years. The RCMAS consists of 
37 items, each of which requires a yes or no answer. There is 
a total score, and 3 anxiety subscales: physiological anxiety, 
worry/oversensitivity, and social concerns. A total scores >15 
is considered clinically significant, and children with clinically 
significant total scores were referred to a pediatric psychiatric 
clinic for further assessment. 
3. Statistical analysis
All data were analyzed using the SPSS ver. 16.0 (SPSS Inc., 
Chicago, IL, USA). Variables data were expressed as mean± 
standard deviation. Correlation between the mean CDI or RCMAS 
scores, and headache frequency, duration, and intensity was 
expressed by the Spearman rank correlation coefficient.  A P 
value of <0.05 was considered statistically significant. 
Results
1. Demographics and clinical characteristics
Of the 720 patients, 412 (57%) were males and 308 (43%) were 
females, with a mean age of 11.7 years (range, 7–17 years). The 
mean age at onset of headache was 9.6 years (range, 5–17 years). 
The mean duration of headache was 11.5 months (range, 1–60 
months). The headache frequency during the last 3 months were 
125 patients (17%) with >15 day/mo, 87 patients (12%) with daily 
headache. 
Five hundred and forty patients (75%) had migraine and 180 
patients (25%) had tension-type headache. Two hundred and 
seventy-three patients (25%) had a family history of migraine 
and 29 patients (4%) had a family history of depression. 
Demographic and clinical characteristics of patients are sum-
marized in Table 1. Twenty patients of 720 headache patients 
were referred to a pediatric psychology clinic for presumed 
psychiatric disorders.
2. Psychological profiles
Thirteen patients exceeded the CDI clinically significant cutoff 
point for increased self-reported depression (CDI score>15). 
Mean total depression score was 18.8±11.2 and the highest score 
was 50. CDI scores in Anhedonia subclass were relatively high. 
Subscores of CDI and RCMAS are shown in Table 2.
Twenty patients exceeded the RCMAS clinically significant 
cutoff point for self-reported anxiety (RCMAS score>15).  Mean 
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total anxiety score was 22.2±6.9 and the RCMAS scores in the 
worry/oversensitivity subclass were relatively high.
There was no correlation between CDI or RCMAS total scores 
and headache frequency, duration, or intensity.
3. Psychiatric diagnosis and treatment
Patients in this study were assessed for behavioral and psy-
chiatric disorders including depression, generalized anxiety 
disorder, bipolar disorder, somatoform disorder, emotional 
disorder and attention deficit/hyperactivity disorder (ADHD) 
(Table 3). Five patients (0.7%) had comorbid pure depression, one 
patient (0.14%) had comorbid pure anxiety disorder, and two 
patients (0.28%) had comorbid depression and anxiety disorder. 
Four patients (0.56%) were diagnosed with somatoform disorder 
and three patients (0.42%) were diagnosed with emotional 
disorder. Four patients (0.56%) were diagnosed with ADHD. A 
patient of referred to psychiatric clinic didn’t have any other 
psychiatric disorders.
All patients received treatment for headaches. Of twenty pa-
tients that referred to a pediatric psychology clinic, ten patients 
were treated with headache medication and psychological 
treatment. Three patients were treated with headache medication, 
antipsychotic medication and psychological treatment. Two 
patients received only psychological treatment. One patient 
received a stimulant for ADHD. 
Discussion
Headache in children are sometimes somatic manifestations 
of psychiatric conditions, such as anxiety and depression6). 
Psychiatric problems have been investigated extensively in 
headache patients, especially in adult patients with migraine. 
However, children with headache have received less attention. 
A recent study investigating psychiatric comorbidity and 
suicide risk in adolescents with chronic daily headaches found 
that these adolescents are at high risk for suicide and have a 
high comorbidity of psychiatric disorders, particularly major 
Table 1. Demographic and clinical data of patients with headache 
(n=720)
Variable Value
Sex
Male/female 412 (57)/308 (43)
Age at headache diagnosis (yr) 11.7 (7–17)
Age at headache onset (yr) 9.6 (5–17)
Duration of headache (mo) 11.5 (1–60)
Headache frequency during the last 3 months
≥15 times/mo 125 (17)
<15 times/mo 595 (83)
Headache severity
Mild (1–3 points) 165 (23)
Moderate (4–6 points) 462 (64)
Severe (7–10 points) 93 (13)
Headache type
Migraine 540 (75)
Migraine without aura 290 (40)
Migraine with aura 157 (22)
Cyclic vomiting 28 (4)
Probable migraine 65 (9)
Tension-type headache 180 (25)
Family history of headache 273 (38)
Family history of psychiatric disorders 29 (4)
Values are presented as number of patients (%) or median (range).
Table 2. CDI and RCMAS raw scores of patients referred to psychiatric 
clinic
CDI and RCMAS Mean±SD (range)
CDI
Negative mood 1.8±1.9 (0–5)
Interpersonal problems 1.5±1.2 (0–4)
Ineffectiveness 4.0±1.9 (0–7)
Anhedonia 6.7±3.2 (2–14)
Negative self-esteem 3.0±1.7 (1–6)
Total depression 18.8±11.2 (5–50)
RCMAS
Physiological anxiety 5.4±2.3 (2–10)
Worry/oversensitivity 8.0±2.6 (2–11)
Social concerns 3.0±2.2 (0–7)
Total anxiety 22.2±6.9 (14–35)
CDI, Children’s Depression Inventory; RCMAS, Revised Children’s Manifest 
Anxiety Scale; SD, standard deviaiton.
Table 3. Psychiatric/behavioral diagnosis in patients with headache
Psychiatric/behavioral diagnosis No. of patients
Depression 10
    Depression only  5
    Depression+somatoform disorder  2
    Depression+emotional disorder  2
Depression+ADHD  1
Anxiety disorder    6
   Anxiety disorder only  1
   Anxiety+ADHD  2
   Anxiety+somatoform disorder  2
  Anxiety+emotional disorder  1
Depression+anxiety  2
ADHD+bipolar disorder  1
ADHD, attention deficit/hyperactivity disorder.
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depression and panic disorders7). In addition, several studies 
reported that psychiatric comorbidities could promote the trans-
formations of episodic headaches into chronic symptoms, which 
in turn can make treatment more difficult and increase the 
likelihood of headache-related disabilities8-10). These findings will 
hopefully increase physician awareness of the importance of 
addressing psychiatric disorders in patients with headache. 
Maizels et al.4) suggested that patients evaluated for headache 
should also be formally screened for depression and anxiety, at 
minimum. Smitherman et al.11) proposed a psychiatric screening 
which can be administered quickly at minimal costs. The most 
common and well-supported self-reporting method used to assess 
depression in children is the CDI and some researchers suggest 
that it may measure broader syndromes of general negative 
emotional distress. However, screening for depression alone is not 
sufficient and should be accompanied by screening for anxiety. 
The RCMAS subscales measure generalized anxiety disorder, 
somatic symptoms and depression. These tests require less time to 
complete and are suitable for use in the outpatient clinic. 
In the headache outpatient clinic in the present study, CDI and 
RCMAS were used to detect depression and anxiety symptoms 
in children with primary headache. Most patients suffered from 
chronic headache before their first visit to the headache clinic 
(mean duration of headache: 11.5 months). Migraine was the 
most common type of headache. Mean total CDI and RCMAS 
scores of referred patients to psychiatric clinic were 18.8 and 22.2. 
These scores were higher than previously published scores from 
control group. Reale et al.12) reported that a normal control group 
had CDI score of 7.0±4.96, while Mazzone et al.13) reported that a 
normal control group had CDI score of 7.20±1.14.
In the present study, behavioral and psychiatric disorders 
including depression, generalized anxiety disorder, bipolar 
disorder, somatoform disorder, emotional disorder and ADHD 
were diagnosed by a pediatric psychologist (Table 3). Point 
seven present of the patients in this study had comorbid pure 
depression, 0.14% had comorbid pure anxiety disorder, and 
0.28% had both comorbid both depression and anxiety disorder. 
Depression was the most common psychiatric disorder with 1.7% 
of subjects diagnosed as clinically depressed. Four patients (0.56 
%) were diagnosed with somatoform disorder and three (0.42%) 
were diagnosed with emotional disorder. Somatoform disorder 
in patients with headache has not been studied as extensively as 
depression or anxiety. In several previous studies, somatoform 
disorder with headache was found to be more prevalent than 
depression and anxiety. Okasha et al.14) found that 43% of 
patients with nonorganic headache had somatoform pain, while 
Nimnuan et al.15) reported that 27% of patients with headache had 
somatoform disorder. Children with multiple somatic complaints 
report symptoms of anxiety and depression more often than 
those with fewer or no somatic complaints. Most patients received 
treatment such as antipsychotic medication or psychotherapy for 
psychiatric disorders16). 
Reale et al.12) reported that indices of behavioral and emotional 
difficulties, anxiety, depression and hyperactivity symptoms 
were elevated among clinically referred children suffering from 
migraine compared to their normal peers. However, most patients 
had behavioral and psychological scores within the normative, 
nonpathological range. 
Previous studies have found that CDI scores correlated posi-
tively with headache frequency. In contrast, this study did not 
observe a correlation between CDI scores and headache frequency, 
duration, or severity. This result was contrary to previous studies 
in which headache frequency and duration were significantly 
associated with depression or anxiety. This discrepancy may be 
due to the relatively high CDI scores observed in patients in the 
present study compared to previous studies.
This study has several limitations. First, it is retrospective study. 
In addition, the screening test for psychiatric symptoms did not 
include assessment of behavioral problems. Last, this study didn’t 
follow up referred patients’ treatment results or effects. 
In conclusion, patients with headache and comorbid psychiatric 
disorder can experience significantly decreased quality of life, 
poor prognoses, chronic diseases, and decreased response to 
treatment. Therefore, early recognition and management of 
psychiatric disorders is potentially of great value to headache 
patients. The authors recommended that all clinicians who 
treat headache patients screen for psychiatric disorders as part 
of their routine clinical evaluation. Screening should include 
symptoms for both anxiety and depression. A comprehensive 
evaluation of headache patients should incorporate formal and 
multidimensional psychiatric screening.
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